These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9771030

  • 1. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG.
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W.
    Bull Int Union Tuberc; 1985 Dec; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008 Dec; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 7. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS, Le HQ, Rikleen D, Davidson P.
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA, Ursov IG.
    Probl Tuberk Bolezn Legk; 2004 Jun; (3):21-6. PubMed ID: 15338895
    [No Abstract] [Full Text] [Related]

  • 11. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG, Chukanov VI, Korneev AA.
    Probl Tuberk; 1996 Feb; (6):42-4. PubMed ID: 9019768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K.
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical aspects and treatment of tuberculosis of respiratory organs in adolescents under present epidemiological conditions].
    Stoiunin MB, Chebotareva TV, Repina ES, Kosina AM, Tochilova TP, Kolotilova ON.
    Probl Tuberk; 1999 Sep; (2):24-7. PubMed ID: 10420744
    [Abstract] [Full Text] [Related]

  • 17. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM.
    Probl Tuberk; 1996 Sep; (3):6-8. PubMed ID: 8754863
    [Abstract] [Full Text] [Related]

  • 18. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C, Velluti G, Mantovani P.
    Arch Monaldi; 1978 Sep; 33(4):251-79. PubMed ID: 116622
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.